The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance
出版年份 2019 全文链接
标题
The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance
作者
关键词
-
出版物
Cancers
Volume 11, Issue 6, Pages 838
出版商
MDPI AG
发表日期
2019-06-17
DOI
10.3390/cancers11060838
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Epithelial‑mesenchymal transition induced by bone morphogenetic protein 9 hinders cisplatin efficacy in ovarian cancer cells
- (2019) Ying Wang et al. Molecular Medicine Reports
- Combinatorial therapy of immune checkpoint and cancer pathways provides a novel perspective on ovarian cancer treatment (Review)
- (2019) Guyu Zhang et al. Oncology Letters
- Expression of zinc finger transcription factors (ZNF143 and ZNF281) in serous borderline ovarian tumors and low-grade ovarian cancers
- (2019) Paweł Sadłecki et al. Journal of Ovarian Research
- SMAD3 inducing the transcription of STYK1 to promote the EMT process and improve the tolerance of ovarian carcinoma cells to paclitaxel
- (2019) Yangyang Shi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MicroRNA in Ovarian Cancer: Biology, Pathogenesis, and Therapeutic Opportunities
- (2019) San-Nung Chen et al. International Journal of Environmental Research and Public Health
- Atezolizumab and Bevacizumab Attenuate Cisplatin Resistant Ovarian Cancer Cells Progression Synergistically via Suppressing Epithelial-Mesenchymal Transition
- (2019) Lei Zhang et al. Frontiers in Immunology
- Regulation of epithelial to mesenchymal transition by BRCA1 in breast cancer
- (2018) Satheesh Kumar Sengodan et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells
- (2018) Rahul Bhattacharya et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Hyaluronic acid conjugated nanoparticle delivery of siRNA against TWIST reduces tumor burden and enhances sensitivity to cisplatin in ovarian cancer
- (2018) Sophia A. Shahin et al. Nanomedicine-Nanotechnology Biology and Medicine
- Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer
- (2018) Sara Al Habyan et al. ONCOGENE
- CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway
- (2018) Linlin Wang et al. ONCOLOGY REPORTS
- Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma
- (2018) Nirmala Jagadish et al. TUMOR BIOLOGY
- Expression of selected epithelial–mesenchymal transition transcription factors in serous borderline ovarian tumors and type I ovarian cancers
- (2018) Pawel Sadlecki et al. TUMOR BIOLOGY
- Role of tumor microenvironment in ovarian cancer pathobiology
- (2018) Alia Ghoneum et al. Oncotarget
- Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC)
- (2018) Young Kwang Chae et al. Scientific Reports
- Snail knockdown reverses stemness and inhibits tumour growth in ovarian cancer
- (2018) N. Hojo et al. Scientific Reports
- CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells
- (2018) Michela Lupia et al. Stem Cell Reports
- MiR-1294 confers cisplatin resistance in ovarian Cancer cells by targeting IGF1R
- (2018) Yong Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- STAT3 regulatedmiR-216apromotes ovarian cancer proliferation and cisplatin resistance
- (2018) Pengfei Jin et al. BIOSCIENCE REPORTS
- Pyruvate dehydrogenase kinase 1 contributes to cisplatin resistance of ovarian cancer through EGFR activation
- (2018) Meng Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Identification of the tumour transition states occurring during EMT
- (2018) Ievgenia Pastushenko et al. NATURE
- Gastric cancer mesenchymal stem cells derived IL-8 induces PD-L1 expression in gastric cancer cells via STAT3/mTOR-c-Myc signal axis
- (2018) Li Sun et al. Cell Death & Disease
- Novel oncogenic and chemoresistance-inducing functions of resistin in ovarian cancer cells require miRNAs-mediated induction of epithelial-to-mesenchymal transition
- (2018) Ling Qiu et al. Scientific Reports
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer of the ovary, fallopian tube, and peritoneum
- (2018) Jonathan S. Berek et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Non-redundant functions of EMT transcription factors
- (2018) Marc P. Stemmler et al. NATURE CELL BIOLOGY
- New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
- (2018) Anushka Dongre et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer
- (2018) Xin Wu et al. Cell Death & Disease
- CCNG1 (Cyclin G1) regulation by mutant-P53 via induction of Notch3 expression promotes high-grade serous ovarian cancer (HGSOC) tumorigenesis and progression
- (2018) Ying Xu et al. Cancer Medicine
- Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models
- (2018) Daniel Newsted et al. OncoImmunology
- IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis
- (2018) Landon Browning et al. Cancer Management and Research
- SIRT6 Is Involved in the Progression of Ovarian Carcinomas via β-Catenin-Mediated Epithelial to Mesenchymal Transition
- (2018) Jun Sang Bae et al. Frontiers in Oncology
- Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer
- (2017) Marta De Donato et al. GYNECOLOGIC ONCOLOGY
- miRNAs and ovarian cancer: An overview
- (2017) Bornali Deb et al. JOURNAL OF CELLULAR PHYSIOLOGY
- A Role for CXCR4 in Peritoneal and Hematogenous Ovarian Cancer Dissemination
- (2017) Agnès Figueras et al. MOLECULAR CANCER THERAPEUTICS
- KDM5A promotes proliferation and EMT in ovarian cancer and closely correlates with PTX resistance
- (2017) Tongfu Feng et al. Molecular Medicine Reports
- Adipose-derived mesenchymal stem cells attenuate cisplatin-induced apoptosis in epithelial ovarian cancer cells
- (2017) Yiping Wen et al. Molecular Medicine Reports
- Context-specific roles of EMT programmes in cancer cell dissemination
- (2017) M. Angela Nieto NATURE CELL BIOLOGY
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- TLR5/7-mediated PI3K activation triggers epithelial-mesenchymal transition of ovarian cancer cells through WAVE3-dependent mesothelin or OCT4/SOX2 expression
- (2017) Ga Bin Park et al. ONCOLOGY REPORTS
- E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness
- (2017) Marina Rosso et al. PLoS One
- Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells
- (2017) Brian Bierie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stress-Activated Chaperones: A First Line of Defense
- (2017) Wilhelm Voth et al. TRENDS IN BIOCHEMICAL SCIENCES
- MicroRNA-20a contributes to cisplatin-resistance and migration of OVCAR3 ovarian cancer cell line
- (2017) Yankun Liu et al. Oncology Letters
- High grade serous ovarian carcinomas originate in the fallopian tube
- (2017) S. Intidhar Labidi-Galy et al. Nature Communications
- Putative stem cells and epithelial-mesenchymal transition revealed in sections of ovarian tumor in patients with serous ovarian carcinoma using immunohistochemistry for vimentin and pluripotency-related markers
- (2017) Natasa Kenda Suster et al. Journal of Ovarian Research
- Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition
- (2017) Shan Deng et al. Oncotarget
- Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells
- (2017) Jun Sakata et al. Oncotarget
- PAX2 maintains the differentiation of mouse oviductal epithelium and inhibits the transition to a stem cell-like state
- (2017) Kholoud Alwosaibai et al. Oncotarget
- NID1, a new regulator of EMT required for metastasis and chemoresistance of ovarian cancer cells
- (2017) Ya Zhou et al. Oncotarget
- Revisiting ovarian cancer microenvironment: a friend or a foe?
- (2017) Boyi Zhang et al. Protein & Cell
- miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway
- (2017) S-L Tung et al. Oncogenesis
- Heterogeneous Cadherin Expression and Multicellular Aggregate Dynamics in Ovarian Cancer Dissemination
- (2017) Yuliya Klymenko et al. NEOPLASIA
- Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer
- (2017) Yuliya Klymenko et al. Cancers
- Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling
- (2017) Chantel Samardzija et al. Scientific Reports
- Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells
- (2017) Maura Sonego et al. Scientific Reports
- The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications
- (2016) Ivo Meinhold-Heerlein et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- The relationship between platinum drug resistance and epithelial–mesenchymal transition
- (2016) Anamaria Brozovic ARCHIVES OF TOXICOLOGY
- EMT, cell plasticity and metastasis
- (2016) Christine L. Chaffer et al. CANCER AND METASTASIS REVIEWS
- Stress Chaperone Mortalin Contributes to Epithelial-to-Mesenchymal Transition and Cancer Metastasis
- (2016) Y. Na et al. CANCER RESEARCH
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo
- (2016) Chanjuan Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma
- (2016) Y. Lou et al. CLINICAL CANCER RESEARCH
- Targeting the tumour microenvironment in ovarian cancer
- (2016) Jean M. Hansen et al. EUROPEAN JOURNAL OF CANCER
- Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance
- (2016) Bernadette M. Boac et al. GYNECOLOGIC ONCOLOGY
- Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment
- (2016) Veronica Rojas et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epithelial-to-Mesenchymal Transition in Paclitaxel-Resistant Ovarian Cancer Cells Is Downregulated by Luteolin
- (2016) Vermont P Dia et al. JOURNAL OF CELLULAR PHYSIOLOGY
- BRCA1/FANCD2/BRG1-Driven DNA Repair Stabilizes the Differentiation State of Human Mammary Epithelial Cells
- (2016) Hua Wang et al. MOLECULAR CELL
- TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial–mesenchymal transition
- (2016) Maria R Amoroso et al. Cell Death & Disease
- Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
- (2016) Chi Lam Au Yeung et al. Nature Communications
- HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation
- (2016) Suresh Bugide et al. CELLULAR ONCOLOGY
- Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop
- (2016) Lan G. Coffman et al. Oncotarget
- BRCA1-IRIS overexpression promotes and maintains the tumor initiating phenotype: implications for triple negative breast cancer early lesions
- (2016) Abhilasha Sinha et al. Oncotarget
- Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy
- (2016) Francesca Ricci et al. Oncotarget
- Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer
- (2016) Shailendra Kumar Dhar Dwivedi et al. Oncotarget
- Cisplatin Resistant Spheroids Model Clinically Relevant Survival Mechanisms in Ovarian Tumors
- (2016) Winyoo Chowanadisai et al. PLoS One
- Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress
- (2016) Carman K. M. Ip et al. Scientific Reports
- Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer
- (2015) Joan L. Walker et al. CANCER
- TGFβ signaling regulates epithelial–mesenchymal plasticity in ovarian cancer ascites-derived spheroids
- (2015) Samah Rafehi et al. ENDOCRINE-RELATED CANCER
- Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers
- (2015) Guoyan Liu et al. JNCI-Journal of the National Cancer Institute
- Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
- (2015) Claudia Allemani et al. LANCET
- Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells
- (2015) Abdullah Alsuliman et al. Molecular Cancer
- The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells
- (2015) Anamaria Brozovic et al. Molecular Oncology
- miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin
- (2015) X Zhu et al. ONCOGENE
- Akt2/ZEB2 may be a biomarker for exfoliant cells in ascitic fluid in advanced grades of serous ovarian carcinoma
- (2015) Changmei Liu et al. TUMOR BIOLOGY
- Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers
- (2015) Guoyan Liu et al. JNCI-Journal of the National Cancer Institute
- Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells
- (2015) Michaela L. Granados et al. PLoS One
- FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells
- (2015) Wen-Tai Chiu et al. Oncotarget
- Liposomal siRNA nanocarriers for cancer therapy
- (2014) Bulent Ozpolat et al. ADVANCED DRUG DELIVERY REVIEWS
- The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer
- (2014) F. Zeppernick et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread
- (2014) Sunila Pradeep et al. CANCER CELL
- Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers
- (2014) Francois Moisan et al. Molecular Oncology
- Oncogenic roles of EMT-inducing transcription factors
- (2014) Alain Puisieux et al. NATURE CELL BIOLOGY
- Tackling the cancer stem cells — what challenges do they pose?
- (2014) Diwakar R. Pattabiraman et al. NATURE REVIEWS DRUG DISCOVERY
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer
- (2014) Q H Miow et al. ONCOGENE
- Resveratrol Inhibits Cisplatin-Induced Epithelial-to-Mesenchymal Transition in Ovarian Cancer Cell Lines
- (2014) Sébastien Baribeau et al. PLoS One
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
- (2014) Limo Chen et al. Nature Communications
- Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer
- (2013) Madhuri Koti et al. BMC CANCER
- Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer
- (2013) W.J. Sheng et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models
- (2013) Ruth Perets et al. CANCER CELL
- Inhibition of mortalin expression reverses cisplatin resistance and attenuates growth of ovarian cancer cells
- (2013) Ling Yang et al. CANCER LETTERS
- Epithelial-to-Mesenchymal Transition and Autophagy Induction in Breast Carcinoma Promote Escape from T-cell-Mediated Lysis
- (2013) I. Akalay et al. CANCER RESEARCH
- Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer
- (2013) Tuan Zea Tan et al. EMBO Molecular Medicine
- MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer
- (2013) Hongping Xia et al. HEPATOLOGY
- Mechanisms that link the oncogenic epithelial–mesenchymal transition to suppression of anoikis
- (2013) Steven M. Frisch et al. JOURNAL OF CELL SCIENCE
- Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden
- (2013) Khalid Abubaker et al. Molecular Cancer
- Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules
- (2013) I. Rizvi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)
- (2013) R Y-J Huang et al. Cell Death & Disease
- Survival for Ovarian Cancer in Europe: The across-country variation did not shrink in the past decade
- (2012) Willi Oberaigner et al. ACTA ONCOLOGICA
- EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
- (2012) Alexandria M Haslehurst et al. BMC CANCER
- Metastatic Colonization Requires the Repression of the Epithelial-Mesenchymal Transition Inducer Prrx1
- (2012) Oscar H. Ocaña et al. CANCER CELL
- TGF- -induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion
- (2012) S. Lamouille et al. JOURNAL OF CELL SCIENCE
- Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -A study of the OVCAD consortium
- (2012) Stefanie Aust et al. Molecular Cancer
- c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin–ATP-binding cassette G2 signaling
- (2012) W K Chau et al. ONCOGENE
- Antagonism of miR-21 Reverses Epithelial-Mesenchymal Transition and Cancer Stem Cell Phenotype through AKT/ERK1/2 Inactivation by Targeting PTEN
- (2012) Mingli Han et al. PLoS One
- Mechanism of tumor resistance to cisplatin mediated by the copper transporter ATP7BThis paper is one of a selection of papers published in a Special Issue entitled CSBMCB 53rd Annual Meeting — Membrane Proteins in Health and Disease, and has undergone the Journal’s usual peer review process.
- (2011) Oleg Y. Dmitriev Biochemistry and Cell Biology
- Cancer Stem Cell Niche: The Place to Be
- (2011) T. Borovski et al. CANCER RESEARCH
- Acquisition of Chemoresistance and EMT Phenotype Is Linked with Activation of the Endothelin A Receptor Pathway in Ovarian Carcinoma Cells
- (2011) L. Rosano et al. CLINICAL CANCER RESEARCH
- Overcoming anoikis - pathways to anchorage-independent growth in cancer
- (2011) M. C. Guadamillas et al. JOURNAL OF CELL SCIENCE
- Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile
- (2011) Ardian Latifi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MicroRNA-200c Represses Migration and Invasion of Breast Cancer Cells by Targeting Actin-Regulatory Proteins FHOD1 and PPM1F
- (2011) S. Jurmeister et al. MOLECULAR AND CELLULAR BIOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Correction: Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity
- (2011) Robert Strauss et al. PLoS One
- Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters
- (2011) M Saxena et al. Cell Death & Disease
- Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin
- (2010) J-C Cheng et al. ONCOGENE
- ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1
- (2010) E Sánchez-Tilló et al. ONCOGENE
- Targeting the Mechanisms of Resistance to Chemotherapy and Radiotherapy with the Cancer Stem Cell Hypothesis
- (2010) Ryan Morrison et al. Journal of Oncology
- Ovarian Low-grade and High-grade Serous Carcinoma
- (2009) Russell Vang et al. ADVANCES IN ANATOMIC PATHOLOGY
- TGF-β-induced epithelial to mesenchymal transition
- (2009) Jian Xu et al. CELL RESEARCH
- Pathogenesis of Ovarian Cancer
- (2009) Robert J. Kurman et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- BRCA1 and its toolbox for the maintenance of genome integrity
- (2009) Michael S.Y. Huen et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells
- (2009) N J Sullivan et al. ONCOGENE
- Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells
- (2009) Nawneet K. Kurrey et al. STEM CELLS
- Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers
- (2009) Dawn R. Cochrane et al. Journal of Oncology
- Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via 5-Integrin, which Is a Therapeutic Target
- (2008) K. Sawada et al. CANCER RESEARCH
- Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression
- (2008) Laurie G. Hudson et al. CLINICAL & EXPERIMENTAL METASTASIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search